MXCT vs WFC · rev $38.6M vs P/E 15, $272.05B cap
MaxCyte Inc (MXCT) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
WFC does not have a complete income-statement cache yet.
MXCT currently screens at market cap $124.3M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the MXCT and WFC stock pages for the full models.
Not investment advice.